Full Text View
Tabular View
No Study Results Posted
Related Studies
MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors
This study is ongoing, but not recruiting participants.
Study NCT00004886   Information provided by National Cancer Institute (NCI)
First Received: March 7, 2000   Last Updated: July 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Interventions listed in this trial
MS-209
docetaxel
Additional drug interventions recognized in this trial
Dofequidar
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
European Organization for Research and Treatment of Cancer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services